Mammalian expression of virus-like particles as a proof of principle for next generation polio vaccines
Open accessThe DOI matches its Crossref record; 70 of the 71 references it cites were found in a registry or an index.
Abstract
Global vaccination programs using live-attenuated oral and inactivated polio vaccine (OPV and IPV) have almost eradicated poliovirus (PV) but these vaccines or their production pose significant risk in a polio-free world. Recombinant PV virus-like particles (VLPs), lacking the viral genome, represent safe next-generation vaccines, however their production requires optimisation. Here we present an efficient mammalian expression strategy producing good yields of wild-type PV VLPs for all three serotypes and a thermostabilised variant for PV3. Whilst the wild-type VLPs were predominantly in the non-native C-antigenic form, the thermostabilised PV3 VLPs adopted the native D-antigenic conformation eliciting neutralising antibody titres equivalent to the current IPV and were indistinguishable from natural empty particles by cryo-electron microscopy with a similar stabilising lipidic pocket-factor in the VP1 β-barrel. This factor may not be available in alternative expression systems, which may require synthetic pocket-binding factors. VLPs equivalent to these mammalian expressed thermostabilized particles, represent safer non-infectious vaccine candidates for the post-eradication era.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures








Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In recent years, PV VLPs with native antigenicity have been produced in various systems, including mammalian cells, plants, insects, bacteria and yeast [129,131,132,133,134,135,136].”
From The Fight against Poliovirus Is Not Over (2023) · cites this paper as [132]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The PyMOL Molecular Graphics System
DeLano, W. L. (2002) · Medical Entomology and Zoology · Cited by 18,147
Liebschner, D., Afonine, P. V., Baker, M. L., Bunkóczi, G., Chen, V. B., Croll, T. I., Hintze, B., Hung, L.-W., Jain, S., McCoy, A. J., et al. (2019) · Acta Crystallographica Section D Structural Biology · doi:10.1107/s2059798319011471 · Cited by 7,953
MotionCor2: anisotropic correction of beam-induced motion for improved cryo-electron microscopy
Zheng, S. Q., Palovcak, E., Armache, J.-P., Verba, K. A., Cheng, Y., & Agard, D. A. (2017) · Nature Methods · doi:10.1038/nmeth.4193 · Cited by 7,777
Pushko, P., Pumpens, P., & Grens, E. (2013) · Intervirology · doi:10.1159/000346773 · Cited by 5,950
RELION: Implementation of a Bayesian approach to cryo-EM structure determination
Scheres, S. H. W. (2012) · Journal of Structural Biology · doi:10.1016/j.jsb.2012.09.006 · Cited by 5,446
CTFFIND4: Fast and accurate defocus estimation from electron micrographs
Rohou, A., & Grigorieff, N. (2015) · Journal of Structural Biology · doi:10.1016/j.jsb.2015.08.008 · Cited by 4,913
New tools for automated high-resolution cryo-EM structure determination in RELION-3
Zivanov, J., Nakane, T., Forsberg, B. O., Kimanius, D., Hagen, W. J., Lindahl, E., & Scheres, S. H. (2018) · eLife · doi:10.7554/elife.42166 · Cited by 4,621
MolProbity: More and better reference data for improved all‐atom structure validation
Williams, C. J., Headd, J. J., Moriarty, N. W., Prisant, M. G., Videau, L. L., Deis, L. N., Verma, V., Keedy, D. A., Hintze, B. J., Chen, V. B., et al. (2018) · Protein Science · doi:10.1002/pro.3330 · Cited by 4,599
Fuerst, T. R., Niles, E. G., Studier, F. W., & Moss, B. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.21.8122 · Cited by 2,089
SPHIRE-crYOLO is a fast and accurate fully automated particle picker for cryo-EM
Wagner, T., Merino, F., Stabrin, M., Moriya, T., Antoni, C., Apelbaum, A., Hagel, P., Sitsel, O., Raisch, T., Prumbaum, D., et al. (2019) · Communications Biology · doi:10.1038/s42003-019-0437-z · Cited by 1,282
Research works printed but not linked: 1
- Racaniello, V. R. In Fields virology (eds David M. Knipe & Peter M. Howley) 453–489 (Wolters Kluwer/Lippincott Williams & Wilkins Health, 2013).
Cited by
Viruses as tools in gene therapy, vaccine development, and cancer treatment
bin Umair, M., Fujimura, N. A., Kashif, H., Seerat-e-Fatima, Butt, F., Azhar, M., Munir, I., Ahmed, M. I., Khalil, W., Sharyar, H., et al. (2022) · Archives of Virology · doi:10.1007/s00705-022-05432-8 · Cited by 54
The Fight against Poliovirus Is Not Over
Mbani, C. J., Nekoua, M. P., Moukassa, D., & Hober, D. (2023) · Microorganisms · doi:10.3390/microorganisms11051323 · Cited by 34
Krug, P. W., Wang, L., Shi, W., Kong, W., Moss, D. L., Yang, E. S., Fisher, B. E., Morabito, K. M., Mascola, J. R., Kanekiyo, M., et al. (2023) · Science Advances · doi:10.1126/sciadv.adg6076 · Cited by 30
Inactivated Poliovirus Vaccine: Recent Developments and the Tortuous Path to Global Acceptance
Sutter, R. W., Eisenhawer, M., Molodecky, N. A., Verma, H., & Okayasu, H. (2024) · Pathogens · doi:10.3390/pathogens13030224 · Cited by 30
“The consortium was able to generate thermostable VLPs that are D-antigenic and have a structure that is indistinguishable from Polio WT virus from a number of expression systems such as plants [85], mammalian cells [86], yeast [87–91] and baculovirus.”
BackgroundViral Nanoparticles‐Mediated Delivery of Therapeutic Cargo
Zanganeh, S., Doroudian, M., Nowzari, Z. R., Nasirmoghadas, P., Nahand, J. S., Sepehrpour, S., & Moghoofei, M. (2023) · Advanced Therapeutics · doi:10.1002/adtp.202300082 · Cited by 26
Metadata
- Authors
- Bahar, M. W., Porta, C., Fox, H., Macadam, A. J., Fry, E. E., & Stuart, D. I.
- Affiliations
- University of Oxford (GB)
- The Pirbright Institute (GB)
- National Institute for Biological Standards and Control (GB)
- Diamond Light Source (GB)
- Corresponding author
- Bahar, Mohammad W.
- Stuart, David I.
- Venue
- npj Vaccines
- Published
- 2021-01-08
- Volume
- 6
- Issue
- 1
- Pages
- 5-5
- ISSN
- 2059-0105 (ISSN-L)
- PMC
- PMC7794334
- OpenAlex
- W3118614350
- Cited by
- 42
- References
- 71
- Citations by year
- 2026: 6 · 2025: 8 · 2024: 11 · 2023: 9 · 2022: 8
- FWCI
- 2.20
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0 (tdm)
- creativecommons.org/licenses/by/4.0 (vor)
- Locations
- npj Vaccines (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- Defra | Animal Health and Veterinary Laboratories Agency (SE2815)
- DEFRA
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Viral Infectious Diseases and Gene Expression in Insects
- Health Sciences › Medicine › Infectious Diseases › Viral Infections and Immunology Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biotechnology › Transgenic Plants and Applications
- Keywords
- poliovirus, virus-like particles, mammalian expression, poliovirus serotypes, neutralizing antibodies, vaccine safety
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Mammalian expression of virus-like particles as a proof of principle for next generation polio vaccines. https://app.cochat.ai/papers/10.1038/s41541-020-00267-3
- The paper
- Bahar, M. W., Porta, C., Fox, H., Macadam, A. J., Fry, E. E., & Stuart, D. I. (2021). Mammalian expression of virus-like particles as a proof of principle for next generation polio vaccines. npj Vaccines. https://doi.org/10.1038/s41541-020-00267-3
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.